Roche Holding AG-Genusschein
13F holders, Q4 2024 (December 31)3holders +1
0new positions
0sold out
$281.92avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Roche Holding AG-Genusschein in their 13F filings, up 1 from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Aristotle Capital Management, LLC ($67.5M), Boston Common Asset Management, LLC ($13.9M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.4M).
- Company
- Roche Holding AG-Genusschein
- CUSIP
- H69293217
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 4,888 shares sold, net −4,888 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Aristotle Capital Management, LLC | 0.13% | Reduce -1.2% | 239,465 | $67.5M |
| Boston Common Asset Management, LLC | 0.41% | Reduce -3.7% | 49,429 | $13.9M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.25% | — | 8,500 | $2.4M |
"% of holder's portfolio" is ROCHE HOLDING AG-GENUSSCHEIN's weight in each manager's 13F, not the share of Roche Holding AG-Genusschein the manager owns.